- Research
- Open access
- Published:
The feasibility and acceptability of delivering and evaluating a physical activity intervention (ACCEPTANCE) for cervical cancer survivors
Pilot and Feasibility Studies volume 11, Article number: 42 (2025)
Abstract
Background
Cervical cancer treatment can be associated with long-term physical, psychological and emotional issues leading to compromised quality of life (QOL). Physical activity (PA) may improve QOL in cervical cancer survivors.
Methods
A one-arm pre/post-feasibility study with parallel process evaluation was conducted to test the feasibility and acceptability of a 12-week PA intervention (ACCEPTANCE). Feasibility was determined by using pre-established criteria relating to inclusion criteria, recruitment and retention, compliance with intervention components and compliance with evaluation measures. The 12-week intervention consisted of (1) an online education session on the benefits of PA and a barrier identification and problem-solving session; (2) a Fitbit monitor; (3) daily and weekly diary entries; (4) brief fortnightly online health coaching sessions; and (5) organising and participating in group walks; (6) online social interaction via a messaging group. Measures included accelerometer assessed PA and sleep, quality-of-life and PA behaviour change questionnaires distributed at 4-time points (baseline, week 6, week 12, and week 24). Process evaluation measures were questionnaires on the acceptance of intervention components and semi-structured interviews with participants after completion.
Results
Thirty participants were recruited with a retention rate of 77% at week 24. The education session, health coaching and Fitbit PA monitor were deemed to be feasible based on compliance rates whilst the online messaging group, diary and group walking compliance suggested that modifications would be needed for these components. Accelerometer and questionnaires were deemed to be feasible evaluation measures based on compliance rates. Process evaluation results suggest that the Fitbit and health coaching sessions were perceived to be the most beneficial aspects of the programme as they enabled self-monitoring of behaviour and goal setting. Unexpected mechanisms of behaviour change were the integration of a small change approach and formation of habits to facilitate PA, whilst barriers to behaviour change included the online, virtual nature of the programme, poor mental health, and environmental challenges. PA levels were higher after the intervention, whilst global QOL was seen to worsen throughout the study, and depression and anxiety symptoms improved.
Conclusions
The ACCEPTANCE study is deemed to be feasible based on criteria established a priori, and only minor modifications would needed to implement in a definitive randomised control trial. The intervention showed potential to increase PA, through hypothesised mechanisms of self-monitoring behaviour and problem solving and unexpected mechanisms such as habit formation.
Trial registration
ISRCTN16349793, Registered 30 September 2020.
Key messages regarding feasibility
-
This study was designed to test the feasibility of delivering and evaluating a 12-week physical activity intervention in women treated for cervical cancer.
-
Feasibility was assessed using pre-determined criteria. Recruitment and retention rates were deemed to be feasible. The inclusion criterion which excludes those meeting the current national physical activity guidelines requires modification to optimise greater representation of women treated for cervical cancer in a subsequent trial. The intervention launch and education session, the Fitbit monitor and health coaching were deemed feasible, whilst the group walking, the messaging group and the diary require modification prior to future implementation. A research-grade accelerometer and questionnaire booklet administered at four time points throughout the study were deemed to be feasible.
-
Only minor modifications in the study methods have been indicated before ACCEPTANCE can be adapted to a definitive randomised control trial.
Introduction
Although cervical cancer (CC) incidence is falling in many countries [1], for those individuals who are diagnosed it can have a life-changing and potentially life-long impact [2]. Post-treatment morbidity can include fatigue, bladder/bowel dysfunction [3], neuropathy [4], sexual dysfunction [5], lymphedema and pelvic pain. Psychological and cognitive impacts are also frequently reported following a CC diagnosis [6, 7], which is not confined to cases of advanced disease, but also affects patients diagnosed at an early stage [8]. As a result, quality of life (QOL) can be negatively impacted [6, 9] and patients who have undergone treatment for CC are documented to have a lower QOL compared to healthy controls [10, 11] and patients treated for other gynaecological malignancies [12, 13].
The age of patients impacted by CC is typically younger than those diagnosed with ovarian, uterine or vulval malignancy, with a peak age incidence in the UK of 30–34 years [14]. Previous work indicates that the aetiological association of CC with the Human Papillomavirus (HPV) can result in feelings of blame, guilt and stigma which may impact psychosocial recovery [8], whilst patients who undergo CC present with more unmet psychological and emotional needs compared to those treated for breast cancer [15]. In addition, CC survivors have reported how a lack of stage-matched peer support can contribute to the creation of unrealistic expectations of the recovery journey [8].
CC survivors are underrepresented in interventions to improve post-treatment QOL [16, 17]. A development study which followed the intervention mapping approach [4] identified physical activity (PA) participation as a viable mechanism to improve QOL after CC. There is an abundance of literature supporting PA interventions after cancer. Reported benefits include reduced fatigue [18, 19], weight loss [20], increased aerobic capacity and cardiovascular health, improved psychological outcomes [21], including symptoms of depression [22], and anxiety [23], along with social benefits [24]. Despite this, levels of PA after gynaecological cancers are low [25,26,27] whilst data on the proportion of CC survivors achieving national PA guidelines has not been reported. As a result, little is known about the types, duration or frequencies of PA that are feasible and acceptable following CC treatment.
Therefore, this study was designed to explore the feasibility and acceptability of delivering and evaluating a multi-component behaviour change intervention focused on increasing PA after CC. The intervention was named ACCEPTANCE (Acceptability in Cervical Cancer of an Exercise Programme Tailored to An oNline Community Environment) and its development was informed by models and relevant theories of behaviour change [4].
Methods
Patient and public involvement
Patient and public involvement (PPI) has informed the development of the research since its inception. Details on the involvement and modes of PPI integration are detailed in the study protocol [28].
Study design
A single-arm pre-/post-feasibility study with parallel process evaluation was conducted through the University Hospitals of Leicester (UHL) NHS Trust, in collaboration with Loughborough University and the University of Leicester in the UK. Ethical approval was granted by the West of Scotland Research Ethics Committee 1 (20/WS/0062) in July 2020. This feasibility trial is reported in line with CONSORT guidelines extended for feasibility trials [29] (Supplementary file S1). The trial registration number was ISRCTN16349793, registered on 30 September 2020.
Sample size justification
The recruitment target was 30 participants, after which recruitment efforts were stopped. The sample size of 30 participants was chosen primarily as it was a realistic target when considering cervical cancer incidence both in the UK and at UHL where recruitment took place. It was also determined based on practical considerations of financial, time and labour resource capacities. Previous feasibility studies of lifestyle and physical activity interventions in endometrial and breast cancer have employed similar sample sizes [30, 31]. Additionally, a sample size of 30 participants affords an adequate precision around the pre-specified retention rate of 70% when applying a 17% margin of error with 95% confidence [32, 33].
Participants
Eligible participants were those aged between 18 and 60 years who had undergone treatment for CC at least 6 months prior or more with curative intent (either surgery, chemoradiotherapy or both modalities) and who were not meeting the national PA guidelines, defined as 150–300 min of moderate to vigorous intensity PA (MVPA) per week [34]. PA-level eligibility was assessed using the Scottish Physical Activity Questionnaire [35]. The age range of 18–60 years was chosen to reflect the Chief Medical Officer (CMO)’s PA adult guidelines which are recommended for adults aged 18–65 years, and to optimise engagement and adherence to a PA programme delivered online [36, 37]. Exclusion criteria were clinical/radiological evidence of disseminated malignancy; pregnancy or breastfeeding; WHO performance status ≥ 3; comorbidity that in the opinion of the patient’s supervising gynaecologist/oncologist would preclude the patient from meeting the study PA requirements; and not resident within the Midlands region in the UK.
Recruitment
Participant recruitment took place via two streams, either (1) patients under clinical follow-up, or (2) advertisements (physical and online) in the general public domain. Those interested were provided with details of the study and screened for eligibility. Consent procedures took place virtually after which all participants were asked to return a signed consent form by post.
Intervention
Details on the intervention development [4] and the study protocol including feasibility objectives [28] have been published previously. Considering the diminished QOL after cervical cancer treatment, the logic model of the problem (i.e. low PA participation in the target group) was developed (Supplementary file 2.4). In brief, the aim of the multi-component intervention was to increase PA levels of the target population, specifically through individual and group-based walking over 12 consecutive weeks. The programme components are underpinned by social cognitive theory (SCT) [38] and informed by the health belief model [36] and theories of self-regulation [39] which were determined via the development of a logic model of change (Supplementary file S2.5).
Participants were firstly allocated into intervention groups of 3–6 people each based on their geographical location. The intervention included group online education provision, problem-solving, barrier identification, and goal setting in relation to increasing PA levels after treatment for CC. Intervention launch sessions were intended to be delivered in person; however, due to restrictions posed as a result of COVID-19, this was adapted to an online session delivered to each participant group. Self-monitoring of PA behaviour was facilitated by providing participants with a programme diary to complete daily and weekly, and a consumer PA device (Fitbit inspire). Throughout the study, peer support through social interaction and group walking amongst participants was encouraged via a messaging platform, which allowed participants to maintain contact and organise group walking sessions. NM prompted group walk organisation via the messaging platform. Participants were instructed and encouraged to post their PA achievements on the online group and to update others in the intervention group on their progress, thereby creating opportunities for social interaction. Individual goals were reviewed fortnightly through online health coaching sessions based on the GROW model [40]. These sessions took place online via video/telephone call administered by the researcher (NM).
Data collection
Participant recruitment, eligibility, and retention rates were collected. Measure completeness (measures completed and returned to the research team) and compliance rates (valid data) were monitored at baseline, week 6, week 12, and week 24. Where possible, reasons for withdrawal were also recorded. Demographic data, treatment-related information and medical history were collected at baseline. Data were collected to describe the launch and education attendance rates, the number of diary entries completed, the number of health coaching sessions attended, the number of participants who posted on the online forum and engaged with the group messaging, the number of participants who took part in a group walk and the frequency of these.
A research-grade blinded accelerometer (GENEActiv Original, Activinsights Ltd., Cambridgeshire, UK) was worn by participants on their non-dominant wrist continuously for 8 days at four evaluation time points (baseline, week 6, week 12, and week 24) to measure PA and sleep. Accelerometers were configured to record at a frequency of 100 HZ. Data from the accelerometer were downloaded using GENEActiv PC software V.3.2 and accelerometer files were processed with R-package GGIR version 2.4–0 [41]. Files were autocalibrated and the magnitude of dynamic acceleration (Euclidean norm minus one in mg, ENMO) averaged over 5-s epochs. Non-wear was imputed using the default setting, that is, invalid data were imputed by the average at similar time-points on different days of the week. Participants were excluded if post-calibration error was > 0.01 g (10 mg), they had < 3 days of valid wear (defined as ≥ 16 h per day), or if wear data were not present for each 15-min period of the 24-h cycle. Sleep logs were used to guide the algorithm to identify the sleep window. Variables of interest were Volume of PA (average acceleration; PA across the whole day measured in mil-li-gravitational units; [mg]), MVPA (the time accumulated in 1-min bouts of > 100 mg), Light PA (the time accumulated with acceleration between 40 and 100 mg), Sedentary behaviour (the time accumulated during the waking day below 40 mg), Sleep duration and Sleep efficiency (the ratio of sleep duration to the duration of the sleep window).
A questionnaire booklet was also administered at baseline, week 12, and week 24. The booklet contained the self-efficacy for walking scale (SEW) [42], PA Enjoyment Scale (PACES) [43], European Organisation for Research and Treatment of Cancer core Quality of Life questionnaire (EORTC QLQ-30), Menopausal Rating Scale [44], Hospital Anxiety and Depression scale (HADS) [45] and the Fatigue Symptom Inventory (FSI) [46]. These constructs were measured as they were identified within the logic model of change and thus would be hypothesised to change in a definitive trial.
Process evaluation
A mixed methods process evaluation was conducted following Medical Research Council (MRC) guidance [47], to understand how the ACCEPTANCE intervention was delivered and its acceptability amongst CC survivors. Questionnaires were developed to evaluate various aspects of the programme including the intervention launch and education session, acceptance of wearing and engaging with the Fitbit activity monitor (administered at week 12 and week 24), and experiences of using the online group messaging platform. A researcher log was completed by NM to record reflections of interactions with participants throughout the duration of the study. Feedback was divided into four categories at the time of collection, including acceptance of programme components; acceptance of intervention evaluation; alterations to future delivery, and barriers to PA. A semi-structured qualitative interview (telephone or virtual video) was conducted with participants after the 6-month evaluation measures to investigate the feasibility and acceptability of the programme components. The evaluation interview schedule (available in Supplementary material S2.1) asked participants about the following: perceptions of the intervention; benefits of participation; experiences of the group walking; reasons for withdrawal (where relevant), maintenance of intervention components and PA behaviour.
Data analysis
Quantitative data was analysed using IBM SPSS statistics 25. Feasibility thresholds were determined a priori in the study protocol using relevant guidance [28, 48]. Means and standard deviations (SDs) were used to describe PA and sleep metrics from the accelerometer at each evaluation time point (baseline = T0; week 6 = T1; week 12 = T2; week 24 = T3). Constructs measured via questionnaire were computed using standard scoring procedures. Change scores were calculated for each outcome for participants who provided data at each time point: T0 and T1; T1 and T2; T2 and T3; T0 and T3. Due to data skewness, only responses from the process evaluation questionnaires representing either “strongly agree” or “agree” for each outcome are reported.
Qualitative data were analysed using template analysis [49], a form of thematic analysis which incorporates a large degree of structure in the analysis, due to the development of a priori themes to guide the analysis process. A priori themes or categories were developed pragmatically using the MRC guidance to reflect the distinct needs of the research and the type of data collected:
-
1.
Delivery: establishing whether the intervention was delivered per protocol, any deviations, and the reasons for and outcomes of these deviations.
-
2.
Views on the intervention: participant experience of the intervention.
-
3.
Mechanisms of impact: exploring hypothesised and unintended impacts of the programme.
-
4.
Contextual factors: understanding the context in which the intervention was delivered.
Interpretations of qualitative data and the study findings more broadly were discussed with PPI members and within the research team to enable the generation of conclusions which transparently and credibly reflect the experiences of participants. Full details of the qualitative and quantitative process evaluation methods are published separately [28] and are available in the associated PhD thesis [50].
Results
Feasibility and acceptability of the intervention
Study eligibility, recruitment, and retention
Forty-seven women expressed an interest in participating in the study, 36 from the hospital recruitment stream (76.6%) and 11 from general recruitment. Of these, 34 individuals were eligible (64%), with the reasons for ineligibly including: already achieving PA guidelines (n = 6); less than 6 months post-treatment (n = 1); no cervical cancer diagnosis (n = 2); and living outside of the study geographical location (n = 4). In total, 30 participants were recruited and consented between October 2020 and April 2021. Reasons for non-participation of the 4 eligible women could not be obtained and a further 2 participants withdrew prior to baseline assessment. Participant demographic information provided at baseline is available in Table 1. The retention rate at week 24 was 76.7%, with 5 participants withdrawing from the study and 2 lost to follow-up (Fig. 1). Reasons for withdrawal were: injury unrelated to the programme (n = 3), a lack of time (n = 1), and a medical issue (n = 1). A participant flow diagram is displayed in Fig. 1 showing attrition throughout the study.
Evaluation measures
Compliance and completeness rates with evaluation measures are displayed in Supplementary file S2.2. Compliance (> 3 days of data) with wearing the accelerometer was very high, although it fell from 100% at baseline to 78.3% at week 24. Completeness of the questionnaire booklets was also high with the lowest completeness rate seen on the MRS at week 6. How results relate to feasibility criteria established a priori are detailed in Table 2.
Process evaluation data indicated that the study measures (accelerometers and questionnaires) were generally well accepted; however, some participants reported that some of the questions impacted them negatively, for example:
Participant struggled to complete the questionnaires, relating this to her poor mental health. She found the questions difficult to understand and found that answering the questionnaire negatively impacted her mood and anxiety. She felt that when she did attempt to answer the questionnaire her answers were not accurate as she would try to protect herself by answering incorrectly (Researcher log, week 13)
This insight also indicates that the validity of certain measures may be compromised within participant groups who report pre-existing mental health problems or where the questions asked reinforce negative feelings.
Intervention components
Adaptations.
Protocol adaptations are any intentional changes or alterations made to the protocol during its delivery to enhance contextual fit [46]. Only one protocol adaptation arose during the implementation of the ACCEPTANCE programme. It became apparent that participants did not have a means of measuring their levels of MVPA. This was despite the aim of the programme being to gradually increase PA levels in line with the national recommendations (150–300 min of MVPA per week). Therefore, it was decided that during the week 6 health coaching session, device-assessed MVPA would be fed back to participants to increase their knowledge of how their activity levels mid-intervention compared with the national recommendations.
Acceptability.
All 28 participants attended the virtual intervention launch and education session, whilst 25 (88%) attended at least 70% of health coaching sessions, and 14 (58%) reported completed diary entries for all 12 weeks. Twenty-three (82%) participants created a profile on the online messaging platform and of these, 18 (64%) posted within their respective group. The mean number of posts made by a participant over the 12 weeks was 9 (SD = 17.48). Four group walks took place over the 12 weeks including 2–3 participants per walk, with a total of 10 (43%) participating in at least one walk. The implications of these results on markers of feasibility are detailed in Table 2.
Mixed methods process evaluation data described the intervention as motivating, facilitative and challenging, exampled by the following participant who took part despite experiencing lower leg neuropathy:
Absolutely loved it. It was the most motivated I'd been in ages because people before have been so quick to sort of say…“Just do what you can, if you if you get out of bed in the morning, then that's all you need to do”. That's not enough for me, so it was so nice to have someone going…. “Yeah, I mean that was good, but can you do like five-thousand more next week?” (P8)
Walking was a well-liked form of PA and those who partook in a group walk reported enjoying the experience and found that socialising with peers was highly beneficial: “it's just really nice to be able to talk to someone who had been in the same situation” (P6). However, a lack of perceived competence and self-esteem were barriers to group walk participation and it was suggested that group walking could be improved if groups were treatment-matched. “I mean they both have the operations, whereas I hadn’t, so perhaps you know they're not up to doing as much as what I was doing” (P15), and ‘Participant reflected that no other women in her group had the same treatment type as her which limited their understanding of her experience. She has suggested that separate stage matched messaging groups be created’ (Researcher log entry, week 8).
Participant feedback collected via process evaluation questionnaires is detailed in Table 3. There was concordant agreement between quantitative and qualitative data to suggest that the Fitbit was the most enjoyed aspect of the programme as it provided participants with prompts to be active and increased knowledge of their steps per day which enabled goal setting: “The Fitbit has been amazing. I feel like I've carried on like monitoring stuff personally …all of the things that I’ve found out” (P11). Despite the intervention launch and education session being perceived as beneficial in terms of information provision, participants reflected on a missed opportunity for social interaction due to the virtual nature of the session: “It might have been better if we could've met in person because I think you can have different interactions and you get to know a bit of their personality as well, rather than just seeing them on a screen” (P5).
Health coaching was well accepted, with participants reporting that they found the fortnightly sessions motivating and an important opportunity for self-reflection. It was also suggested that these sessions acted as a form of social support during COVID-19 restrictions in the absence of group walking with other participants: “Covid fought hard against the group support, but in terms of support network from me to you, that was invaluable, and I found that reallybeneficial” (P16). On the other hand, 10 out of 18 participants disagreed that the messaging group was an effective means of organising group walks (Table 3), exampled qualitatively: “You know nobody really bothered, and I found that a bit of a waste of time”. It was suggested that organisation of walks would have been more effective had they been researcher-led rather than peer-led:
I think for me if somebody had sort of taken the lead or you know if you had said…right, on this date why don't we all meet up? Because it felt like every time we tried to organize a meet up it was like…well I can't really do this, then I can't really do that (P8).
This is further supported by one-third of participants reporting that they did not feel comfortable posting on the online messaging platform (Table 2), which was a barrier to virtual communication and peer support.
Finally, the diary was viewed as a useful reflection tool, for example, “I did briefly reflect on the diary and went back on it from different weeks and I think my mood got better throughout the course” (P21), although weekly entries to rate psychological/physical symptoms were perceived as challenging due to fluctuations throughout the week.
Potential changes to behaviour and health
PA, sleep, and wellbeing measures
The volume of PA, MVPA and light activity increased overall from baseline to week 24, whilst sedentary time was lower at week 24 compared to baseline. There were very small changes in sleep duration and sleep efficiency scores which were seen to decrease from baseline to week 24 (Table 4).
Well-being
Scores on the EORTC global QOL subscale decreased from baseline to week 24. The following EORTCQLQ-30 subscales worsened from baseline to week 24: emotional functioning, physical functioning, cognitive functioning, social functioning, role functioning, and fatigue. In contrast, improvements from baseline to week 24 were seen with: pain and insomnia symptoms. Global QOL and insomnia symptoms represent the largest changes seen from baseline to follow-up (Table 5). Menopause-related QOL decreased from baseline to week 24 (Table 6). Both the depression and anxiety subscales of the HADS questionnaire saw overall improvements in symptomology scores from baseline to week 24, whilst fatigue scores also improved from baseline to week 24.
Mechanisms of impact
Concordant agreement between quantitative and qualitative data suggested that there was an impact of self-monitoring strategies and increased awareness of participant’s own behaviour, of their capabilities and of the PA guidelines on perceived self-efficacy for walking and PA enjoyment. It was also evident that despite in-person social interaction being impacted by the COVID-19 pandemic, online encouragement from other participants was found to be encouraging. Recognising the benefits of PA was a facilitator to programme participation as those who took time the time to reflect on the knock-on benefits found that this increased the value that they placed on PA:
I mean I'm not over the depression, but I feel like my days used to be really bad, where I would sit and cry. Now, I feel like I haven’t had a real bad day for…. I can't even remember …you still have your days when you think I can’t be bothered but I still move, even if it's just around the house trying to hit the 250 an hour (P11).
Unexpected mechanisms of impact were the development of habitual PA behaviours, with the integration of rituals (e.g. walking instead of driving; taking the stairs instead of the lift) into daily routines. Goal setting was broken down into a small change approach, making goals more achievable and which were spread throughout the week. PA time was perceived as a type of ‘self-care’ and a way for participants to prioritise their own health, separate from their caring responsibility roles.
When I do go out for these walks by myself, I love it so much. It might sound selfish to some people but it’s taking time for yourself because obviously if you’re not in the right state of mind, if you’re not looking after yourself then everyone is going to suffer around you (P3).
Barriers to behaviour change mainly related to factors that hindered social interaction between participants, in particular, the virtual platform and poor mental health. Barriers to walking included safety of the environment to walk alone: “By the time you've got the kids to bed and you’re both home together…. It's like seven o'clock and then I don't feel safe enough to walk, so it's hard” (P7). Other barriers were physical issues, such as hip pain and fatigue.
The COVID-19 pandemic created an unprecedented and ambiguous context for the evaluation of ACCEPTANCE. In particular, restrictions on travel and socialisation, and resulting poor mental health interfered with group walking and consequentially may have impacted the evaluation outcomes (e.g. QOL).
Discussion
This is the first study to report the feasibility and acceptability of delivering and evaluating a PA programme (ACCEPTANCE) in CC survivors. The recruitment and retention rates for this study indicate that a future randomised controlled trial of ACCEPTANCE would be feasible, although as shown, self-reported PA levels may not be an appropriate eligibility criterion since achieving the national PA recommendations accounted for 50% of ineligibility. Alternative PA levels could be considered. One of the advantages of ACCEPTANCE is its individualised programme with 2-weekly health coaching sessions enabling goal setting to be tailored to participants’ individual circumstances. Evaluation of similar coaching sessions within behaviour change interventions has shown them to be a motivating factor for maintaining behaviour change [51, 52]. Previous research has demonstrated the feasibility of e-health technologies in combination with health coaching [53] and the current study builds on this to support its maintenance over a 12-week duration. Given that the diary component requires modification, it may also be viable to integrate such reflective and self-monitoring mechanisms into an e-health technology application to reduce the burden of an additional component completion. Emotional support received from fellow survivors is highly valuable [54]; however, peer support was not seen to be optimised in the intervention due to the virtual nature of many aspects and due to group walks requiring peer-led organisation. Given that in-person peer support was preferred by participants, focus on enabling participation in group walking via structured researcher-led organisation should be prioritised.
Results indicated that ACCEPTANCE has the potential to increase participants’ PA. The volume of PA increases of 1 mg (5–6 min of brisk walking) per day is meaningful [55], indicating that increases seen could equate to 20 min of brisk walking per day. Additionally, the increases in MVPA of 11.45 min per day from baseline to follow-up are considerably higher when compared to a change of + 6.1 min per day in a population of breast cancer survivors measured using hip-worn accelerometry [56]. The process evaluation found that such changes were attributable to expected mechanisms of self-monitoring and graded goal setting, along with unexpected mechanisms of integrating a small change approach [57] to goal setting and habit formation [58] to facilitate PA participation, which have been integrated into a refined logic model (Supplementary file S3.3).
Self-reported QOL scores were seen to decline throughout the study when measured using the QLQ-C30 global QOL scale with the follow-up score of 57.89 being comparable to patients undergoing treatment for CC [59, 60]. It must be noted that the study was conducted during the COVID-19 pandemic and participants qualitatively reported that their mental and social health was negatively impacted by restrictions on socialisation and travel. This suggests that declining QOL scores may be predominantly reflecting declines in social facets of QOL. This is further supported by improvements in anxiety and depression symptomology measured using the HADS from baseline to follow-up and such evidence was also reiterated via qualitative evaluation findings. However, baseline scores for both anxiety and depression were within the clinical range, suggesting that psychological and emotional well-being are a significant concern for this population, which is supported by findings from previous investigations [8, 9].
There are a number of conflicting results from the current study, such as a decline in menopause-related QOL and fatigue along with large improvements in insomnia symptoms, yet a decline in sleep duration. The variability in these results, including the decline in QOL scores may be attributable to a number of factors (e.g. natural fluctuations, COVID-19 restrictions and questionnaire use). Thus, further investigation which moves beyond that of feasibility testing, includes a control group and has the ability to account for treatment-related and sociodemographic factors is needed to ascertain any impact of the intervention alongside identifying potential confounders. Given that QOL is identified in the intervention development logic models, the implications of its measurement and conceptualisation should be considered carefully given its decline in the current trial. For example, the potential use of more frequent and rapidly administered ecological momentary assessment tools ought to be considered as a viable avenue to better gauge the nuanced well-being of participants in a definitive trial [61], helping to avoid inaccuracies which naturally arise from aggregated, past experiences [62]. Challenges related to reflecting on well-being were also highlighted by participants in relation to the diary completion, further emphasizing the need for a well-being measure which takes into account daily and weekly fluctuations.
This study’s results suggest there is interest in a behaviour change programme which can target CC survivors’ needs after treatment and that there are potential psychological and physical benefits of the ACCEPTANCE programme which can be further optimised subject to intervention refinement. This is in line with previous research findings that positive changes in health behaviours are associated with significant improvements in QOL in CC survivors [63]. Going forward, given that the majority of participants were of White British ethnicity (92.9%) which does not reflect the ethnic diversity seen in the UK CC population [1], strategies to engage and support CC survivors from ethnic minority groups should be prioritised. Such strategies could foster the inclusion of ethnic minority patients in a PPI, community or healthcare professional groups to understand specific barriers and facilitators to participation, alongside the utilisation resources which consider the communication needs (e.g. language, trust and relatability) of non-English speakers and recruitment strategies which target spaces frequented by ethnic minority groups [64, 65]. Whilst ACCEPTANCE may have the potential to increase PA levels and provide emotional support, greater and more structured targeting of peer support is recommended to potentially impact overall QOL (e.g. social health). A future randomised trial is needed to ascertain the effectiveness of the ACCEPTANCE intervention.
Limitations
This feasibility trial was subject to some methodological limitations. Despite the programme evaluation benefitting from measures taken at multiple time points, there was noticeable attrition at the end of the programme (week 12). Change scores in outcomes represent differences between participants who completed measures at each time point, and thus comparison of outcomes is limited by less representation at week 12 to determine optimal programme length and to aid comparison of outcomes. In terms of feasibility evaluation, Fitbit compliance reported in this study refers to those who completed the evaluation questionnaire at week 12. An objective measure of Fitbit compliance throughout the programme would have provided greater insight into its acceptability. With regards to the process evaluation, despite 77% of participants taking part in an interview, only one of these participants had withdrawn, so it is likely that there are further barriers to participation that were not captured by these accounts.
Conclusion
Only minor modifications in the study methods have been indicated before ACCEPTANCE can be adapted to a definitive randomised control trial. Recruitment and retention rates were deemed to be feasible, however, recruitment strategies and eligibility criteria require modification to increase the scope of the trial to offer the programme to those who may be excluded due to their PA levels and to those who are from ethnic minority groups. The study showed potential to increase physical activity, through hypothesised mechanisms of self-monitoring behaviour and problem solving, and unexpected mechanisms such as habit formation.
Data availability
Data is unavailable due to ethical restrictions.
References
Moss E, Askew S, Cheung S, Dawson P, Singh K, Redman CW, et al. The effect of country of birth on the pattern of disease and survival from cervical cancer. J Low Genit Tract Dis. 2016;20(1):38–43.
Moss EL, Taneja S, Munir F, Kent C, Robinson L, Potdar N, et al. Iatrogenic menopause after treatment for cervical cancer. Clin Oncol (R Coll Radiol). 2016;28(12):766–75.
Pieterse QD, Kenter GG, Maas CP, de Kroon CD, Creutzberg CL, Trimbos JB, et al. Self-reported sexual, bowel and bladder function in cervical cancer patients following different treatment modalities: longitudinal prospective cohort study. Int J Gynecol Cancer. 2013;23(9):1717–25.
Millet N, McDermott HJ, Moss EL, Edwardson CL, Munir F. Increasing physical activity levels following treatment for cervical cancer: an intervention mapping approach. J Cancer Surviv. 2022;16(3):650–8.
Membrilla-Beltran L, Cardona D, Camara-Roca L, Aparicio-Mota A, Roman P, Rueda-Ruzafa L. Impact of cervical cancer on quality of life and sexuality in female survivors. Int J Env Res Pub He. 2023;20(4):3751.
Le Borgne G, Mercier M, Woronoff AS, Guizard AV, Abeilard E, Caravati-Jouvenceaux A, et al. Quality of life in long-term cervical cancer survivors: a population-based study. Gynecol Oncol. 2013;129(1):222–8.
Wefel JS, Vardy J, Ahles T, Schagen SB. International cognition and cancer task force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol. 2011;12(7):703–8.
Millet N, Moss EL, Munir F, Rogers E, McDermott HJ. A qualitative exploration of physical and psychosocial well-being in the short and long term after treatments for cervical cancer. Eur J Cancer Care. 2022;31(2): e13560.
Ferrandina G, Mantegna G, Petrillo M, Fuoco G, Venditti L, Terzano S, et al. Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: a prospective, longitudinal study. Gynecol Oncol. 2012;124(3):389–94.
Pfaendler KS, Wenzel L, Mechanic MB, Penner KR. Cervical cancer survivorship: long-term quality of life and social support. Clin Ther. 2015;37(1):39–48.
Lee Y, Lim MC, Kim SI, Joo J, Lee DO, Park SY. Comparison of quality of life and sexuality between cervical cancer survivors and healthy women. Cancer Res Treat. 2016;48(4):1321–9.
Korfage IJ, Essink-Bot ML, Mols F, van de Poll-Franse L, Kruitwagen R, van Ballegooijen M. Health-related quality of life in cervical cancer survivors: a population-based survey. Int J Radiat Oncol Biol Phys. 2009;73(5):1501–9.
Distefano M, Riccardi S, Capelli G, Costantini B, Petrillo M, Ricci C, et al. Quality of life and psychological distress in locally advanced cervical cancer patients administered pre-operative chemoradiotherapy. Gynecol Oncol. 2008;111(1):144–50.
Cancer Research UK. Cervical cancer Incidence. https://www.cancerresearchuk.org/health-professional/cancerstatistics/statistics-by-cancer-type/cervical-cancer/incidence. Accessed Mar 2025.
Faller H, Brähler E, Härter M, Kellere M, Schulz H, Wegscheider K, et al. Unmet needs for information and psychosocial support in relation to quality of life and emotional distress: a comparison between gynecological and breast cancer patients. Patient Educ Couns. 2017;100(10):1934–42.
Smits A, Lopes A, Das N, Bekkers R, Massuger L, Galaal K. The effect of lifestyle interventions on the quality of life of gynaecological cancer survivors: a systematic review and meta-analysis. Gynecol Oncol. 2015;139(3):546–52.
Beesley VL, Alemayehu C, Webb PM. A systematic literature review of trials of survivorship interventions for women with gynaecological cancer and their caregivers. Eur J Cancer Care. 2019;28(3):e13057.
Hilfiker R, Meichtry A, Eicher M, Nilsson Balfe L, Knols RH, Verra ML, et al. Exercise and other non-pharmaceutical interventions for cancer-related fatigue in patients during or after cancer treatment: a systematic review incorporating an indirect-comparisons meta-analysis. Br J Sports Med. 2018;52(10):651–8.
Sabiston CM, Brunet J. Reviewing the benefits of physical activity during cancer survivorship. Am J Lifestyle Med. 2012;6(2):167–77.
McCarroll ML, Armbruster S, Pohle-Krauza RJ, Lyzen AM, Min S, Nash DW, et al. Feasibility of a lifestyle intervention for overweight/obese endometrial and breast cancer survivors using an interactive mobile application. Gynecol Oncol. 2015;137(3):508–15.
Teychenne M, White RL, Richards J, Schuch FB, Rosenbaum S, Bennie JA. Do we need physical activity guidelines for mental health: what does the evidence tell us? Ment Health Phys Act. 2020;18: 100315.
Galiano-Castillo N, Ariza-Garcia A, Cantarero-Villanueva I, Fernandez-Lao C, Diaz-Rodriguez L, Arroyo-Morales M. Depressed mood in breast cancer survivors: associations with physical activity, cancer-related fatigue, quality of life, and fitness level. Eur J Oncol Nurs. 2014;18(2):206–10.
Rogers LQ, Courneya KS, Anton PM, Verhulst S, Vicari SK, Robbs RS, et al. Effects of a multicomponent physical activity behavior change intervention on fatigue, anxiety, and depressive symptomatology in breast cancer survivors: randomized trial. Psychooncology. 2017;26(11):1901–6.
Burke S, Wurz A, Bradshaw A, Saunders S, West MA, Brunet J. Physical activity and quality of life in cancer survivors: a meta-synthesis of qualitative research. Cancers (Basel). 2017;9(5):58 1–29.
Bifulco G, De Rosa N, Tornesello ML, Piccoli R, Bertrando A, Lavitola G, et al. Quality of life, lifestyle behavior and employment experience: a comparison between young and midlife survivors of gynecology early stage cancers. Gynecol Oncol. 2012;124(3):444–51.
Nayak P, Vernon SW, Savas LS, Basen-Engquist K, Morgan RO, Elting LS. Functional impairment and physical activity adherence among gynecologic cancer survivors -. Int J Gynecol Cancer. 2016;26(2):381–8.
Christiansen MG, Piil K, Jarden M. The symptom experience and self-management strategies of women undergoing cervical cancer treatment: a qualitative study. Cancer Nurs. 2022;45(1):12–20.
Millet N, McDermott HJ, Munir F, Edwardson CL, Moss EL. ACCEPTANCE: protocol for a feasibility study of a multicomponent physical activity intervention following treatment for cervical cancer. BMJ Open. 2022;12(1): e048203.
Eldridge SM, Chan CL, Campbell MJ, Bond CM, Hopewell S, Thabane L, et al. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. BMJ. 2016;355: i5239.
Pullen T, Sharp P, Bottorff JL, Sabiston CM, Campbell KL, Ellard SL, et al. Acceptability and satisfaction of project MOVE: a pragmatic feasibility trial aimed at increasing physical activity in female breast cancer survivors. Psychooncology. 2018;27(4):1251–6.
Rossi A, Frechette L, Miller D, Miller E, Friel C, Van Arsdale A, et al. Acceptability and feasibility of a Fitbit physical activity monitor for endometrial cancer survivors. Gynecol Oncol. 2018;149(3):470–5.
Sim J, Lewis M. The size of a pilot study for a clinical trial should be calculated in relation to considerations of precision and efficiency. J Clin Epidemiol. 2012;65(3):301–8.
Hertzog MA. Considerations in determining sample size for pilot studies. Res Nurs Health. 2008;31(2):180–91.
Davies DSC, Atherton F, McBride M, Calderwood C. UK chief medical officers’ physical activity guidelines. Dep Health Soc Care. 2019(September):1–65.
Lowther M, Mutrie N, Loughlan C, McFarlane C. Development of a Scottish physical activity questionnaire: a tool for use in physical activity interventions. Br J Sports Med. 1999;33(4):244–9.
Pope Z, Lee JE, Zeng N, Lee HY, Gao Z. Feasibility of smartphone application and social media intervention on breast cancer survivors’ health outcomes. Transl Behav Med. 2019;9(1):11–22.
Smith A. Older adults and technology use. 2014. https://www.pewresearch.org/internet/2014/04/03/older-adults-andtechnology-use/. Accessed Mar 2025.
Bandura A. Social foundations of thought and action. Englewood Cliffs, NJ. 1986;1986(23–28):2.
Janz NK, Becker MH. The health belief model: a decade later. Health Educ Q. 1984;11(1):1–47.
Lunsford LG. Emergent goals in mentoring and coaching. In Beyond Goals: Effective Strategies for Coaching and Mentoring. Taylor and Francis. 2016. p. 275–88. https://doiorg.publicaciones.saludcastillayleon.es/10.4324/9781315569208.
Migueles JH, Rowlands AV, Huber F, Sabia S, van Hees VT. GGIR: a research community–driven open source R package for generating physical activity and sleep outcomes from multi-day raw accelerometer data. Journal for the Measurement of Physical Behaviour. 2019;2(3):188–96.
McAuley E, Blissmer B, Katula J, Duncan TE. Exercise environment, self-efficacy, and affective responses to acute exercise in older adults. Psychol Health. 2000;15(3):341–55.
Kendzierski D, DeCarlo KJ. Physical activity enjoyment scale: two validation studies. J Sport Exerc Psychol. 1991;13(1):50–64.
Hauser G, Huber I, Keller P, Lauritzen C, Schneider H. Evaluation der klinischen beschwerden (menopause rating scale). Zentralbl Gynakol. 1994;116(1):16–23.
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.
Stein KD, Jacobsen PB, Blanchard CM, Thors C. Further validation of the multidimensional fatigue symptom inventory-short form. J Pain Symptom Manage. 2004;27(1):14–23.
Moore GF, Audrey S, Barker M, Bond L, Bonell C, Hardeman W, et al. Process evaluation of complex interventions: Medical Research Council guidance. BMJ. 2015;350: h1258.
Thabane L, Ma J, Chu R, Cheng J, Ismaila A, Rios LP, et al. A tutorial on pilot studies: the what, why and how. BMC Med Res Methodol. 2010;10(1): 1.
King N. Doing template analysis. Qual Organ Res. 2012;26:426.
Millet N. The development, implementation, and evaluation of a behaviour change intervention targeting physical activity after treatments for cervical cancer (Doctoral dissertation, Loughborough University). 2022.
Biddle SJ, Edwardson CL, Gorely T, Wilmot EG, Yates T, Nimmo MA, et al. Reducing sedentary time in adults at risk of type 2 diabetes: process evaluation of the STAND (Sedentary Time ANd Diabetes) RCT. BMC Public Health. 2017;17:1–11.
Edwardson CL, Yates T, Biddle SJH, Davies MJ, Dunstan DW, Esliger DW, et al. Effectiveness of the Stand More AT (SMArT) Work intervention: cluster randomised controlled trial. BMJ. 2018;363: k3870.
Gell NM, Grover KW, Humble M, Sexton M, Dittus K. Efficacy, feasibility, and acceptability of a novel technology-based intervention to support physical activity in cancer survivors. Support Care Cancer. 2017;25(4):1291–300.
Moon TJ, Chih MY, Shah DV, Yoo W, Gustafson DH. Breast cancer survivors’ contribution to psychosocial adjustment of newly diagnosed breast cancer patients in a computer-mediated social support group. J Mass Commun Q. 2017;94(2):486–514.
Rowlands A, Davies M, Dempsey P, Edwardson C, Razieh C, Yates T. Wrist-worn accelerometers: recommending~ 1.0 mg as the minimum clinically important difference (MCID) in daily average acceleration for inactive adults. British journal of sports medicine. 2021;55(14):814–5.
Sabiston CM, Brunet J, Vallance JK, Meterissian S. Prospective examination of objectively assessed physical activity and sedentary time after breast cancer treatment: sitting on the crest of the teachable moment. Cancer Epidemiol Biomark Prev. 2014;23(7):1324–30.
Hills AP, Byrne NM, Lindstrom R, Hill JO. “Small changes” to diet and physical activity behaviors for weight management. Obes Facts. 2013;6(3):228–38.
Hagger MS. Habit and physical activity: Theoretical advances, practical implications, and agenda for future research. Psychol Sport Exerc. 2019;42:118–29.
Bjelic-Radisic V, Jensen PT, Vlasic KK, Waldenstrom A-C, Singer S, Chie W, et al. Quality of life characteristics inpatients with cervical cancer. Eur J Cancer. 2012;48(16):3009–18.
Thapa N, Maharjan M, Xiong Y, Jiang D, Nguyen TP, Petrini MA, et al. Impact of cervical cancer on quality of life of women in Hubei, China. Sci Rep. 2018;8(1):11993.
Shiffman S, Stone AA, Hufford MR. Ecological momentary assessment. Annu Rev Clin Psychol. 2008;4:1–32.
Thong MSY, Chan RJ, van den Hurk C, Fessele K, Tan W, Poprawski D, et al. Going beyond (electronic) patient-reported outcomes: harnessing the benefits of smart technology and ecological momentary assessment in cancer survivorship research. Support Care Cancer. 2021;29(1):7–10.
Iyer NS, Osann K, Hsieh S, Tucker JA, Monk BJ, Nelson EL, et al. Health behaviors in cervical cancer survivors and associations with quality of life. Clin Ther. 2016;38(3):467–75.
Darko N, Millet N, Usman A, Teece L, Moss E. Exploring the perspectives of underrepresented voices: Perceptions and experiences of uterine cancer for black African, Caribbean, black British, and mixed-black women in the UK to develop strategies for early symptom presentation. Gynecol Oncol. 2024;180:132–8.
Darko N. Engaging Black and Minority Ethnic Groups in Health Research:‘Hard to Reach’? Demystifying the Misconceptions: Policy Press. Bristol: Bristol University Press; 2021.
Acknowledgements
The research team would like to thank the study participants. The views expressed are those of the authors and not necessarily those of the ESRC, Leicester’s Hospitals Charity, the NIHR or the Department of Health and Social Care.
Funding
Economic and Social Research Council (ESRC) PhD studentship ES/P000711/1 (Nessa Millet) and Leicester’s Hospitals NHS Trust, and supported by the National Institute for Health and Care Research (NIHR) Leicester Biomedical Research Centre (BRC). This is a summary of independent research funded by ESRC and carried out at the National Institute for Health and Care Research (NIHR) Leicester Biomedical Research Centre(BRC). The views expressed are those of the author(s) and not necessarily those of the ESRC, the NIHR or the Department of Health and Social Care.
Author information
Authors and Affiliations
Contributions
Conceptualisation: EM, HM, and FM; methodology: FM, NM, CE, EM, HM, and TP; data collection: NM; formal analysis and investigation: NM, TP; writing—original draft preparation: NM, EM and FM. Writing—review and editing: all authors. All authors have read and agreed to the published version of the manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
Ethical approval was granted by the West of Scotland Research Ethics Committee 1 (20/WS/0062) in July 2020. Informed consent was obtained from all participants involved in the study.
Consent for publication
Consent for publication was obtained by all participants involved in the study.
Competing interests
EM has served on advisory boards for Inivata and GlaxoSmithKline; received speaker fees from GlaxoSmithKline; has received research grants from Intuitive Surgical, British Gynaecological Cancer Society and Hope Against Cancer for unrelated work. All other authors certify that they have no affiliations with or involvement in any organisation or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Supplementary Material 1. CONSORT checklist of information to include when reporting a pilot trial*.
40814_2025_1622_MOESM2_ESM.docx
Supplementary Material 2: Table S2.1. Qualitative interview questions. Table S2.2. Compliance and completeness with evaluation measures at each time point. Figure S2.3. The logic model of the Problem. NOTE: PA= physical activity. Figure S2.4. The logic model of change. NOTE: PA= physical activity. Figure S2.5. Refined ACCEPTANCE logic model following process evaluation. NOTE: Content with a strike through has been removed; content in red font has been added.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Millet, N., McDermott, H.J., Munir, F. et al. The feasibility and acceptability of delivering and evaluating a physical activity intervention (ACCEPTANCE) for cervical cancer survivors. Pilot Feasibility Stud 11, 42 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s40814-025-01622-8
Received:
Accepted:
Published:
DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s40814-025-01622-8